Sort
50,496 grants matching “lung cancer”
Developmental Funds
$535,817Jennifer A Pietenpol · Vanderbilt University · P30 · FY2010 · CA
Adrenergic control of circadian rhythms in CD8 T cells responding to influenza
$535,814John David Farrar · Ut Southwestern Medical Center · R01 · FY2025 · AI
Molecular biomarkers of airway and lung linking COPD and Lung Cancer
$535,797Avrum E Spira · Boston University Medical Campus · R01 · FY2012 · CA
Profiling genome-wide circulating ncRNAs for the early detection of lung cancer
$535,765Youping Deng · University Of Hawaii At Manoa · R01 · FY2019 · CA
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
$535,737Mathewos Tessema · Lovelace Biomedical & Environmental Research Institute · R01 · FY2017 · CA
Comprehensive, context-aware, functional analysis of Cytochrome P450 variants
$535,729Maitreya J Dunham · University Of Washington · R01 · FY2020 · GM
Understanding EGF receptor activation by growth factors and oncogenic mutations
$535,711Mark A. Lemmon · Yale University · R01 · FY2017 · CA
Estimating Overdiagnosis in Cancer Screening Studies
$535,700Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Characterization of human antibodies to sialyl-Lewis A (sLeA) derived from patien
$535,666Philip O. Livingston · Mabvax Therapeutics, Inc. · R42 · FY2010 · CA
Networks Tools to Understand Sex- and Gender-Specific Drivers of Disease
$535,613Dawn L Demeo · Brigham And Women'S Hospital · R01 · FY2023 · HG
Varicella virus antigens in glioma etiology and survival
$535,578Joseph Leo Wiemels · University Of California, San Francisco · U01 · FY2014 · CA
The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk
$535,542Mahdi Sheikh · International Agency For Res On Cancer · U01 · FY2025 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$535,514David B Shackelford · University Of California Los Angeles · R01 · FY2025 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$535,514David B Shackelford · University Of California Los Angeles · R01 · FY2022 · CA
A new imaging approach to radiotherapy planning for lung cancer
$535,497Rahim R Rizi · University Of Pennsylvania · R01 · FY2017 · CA
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
$535,474Harini Veeraraghavan · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver
$535,456Gikas S Mageras · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Networks Tools to Understand Sex- and Gender-Specific Drivers of Disease
$535,451Dawn L Demeo · Brigham And Women'S Hospital · R01 · FY2022 · HG
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$535,436Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Engineered Nanoformulation for Immune-modulation in Cancer
$535,400Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
The Impact of Oxidative Stress on HIV-induced Lung Disease
$535,397Julio Alberto Ramirez · University Of Louisville · U01 · FY2013 · HL
Validating Molecular Signature Risk Models of NSCLC
$535,358David H Harpole · Duke University · R01 · FY2007 · CA
Genomics and Functional Characterization of NF1-mutated Lung Cancer
$535,334Eric Collisson · University Of California, San Francisco · R01 · FY2022 · CA
EZH2 in cancer biology and novel inhibitors
$535,301Jun Qi · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis
$535,285Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA